comparemela.com

Latest Breaking News On - Kigali april - Page 1 : comparemela.com

Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies

Medicines for Malaria Venture (MMV) and Novartis announce positive data from their phase II/III CALINA study, demonstrating that a novel formulation of Coartem® developed for babies weighing less than 5kg with malaria has the required pharmacokinetic profile and therefore efficacy and safety. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.